Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin.

To investigate the pharmacokinetic and pharmacodynamic interaction of the antithrombotic pentasaccharide fondaparinux (Org31540/SR90107A), given subcutaneously, and oral warfarin in healthy subjects.